Bruker has formed a new, single division out of the various spatial biology assets it has acquired over the years. Now under a single operational banner, it includes the company’s previous Bruker ...

NanoString is an Established Leader and Valuable Innovator in Gene Expression Profiling and Spatial Transcriptomics for Scientific and Clinical Research in Healthcare Under the asset purchase ...

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability ...

Adds Highly Complementary Business in Gene Expression Profiling and Spatial Transcriptomics for Discovery and Translational Research Under the asset purchase agreement, Bruker has now acquired ...

Bruker (NASDAQ:BRKR) will buy NanoString Technologies, a Seattle-based innovator in gene expression profiling and spatial transcriptomics for ~$392.6M in cash, and the assumption of certain ...

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquartered in Seattle ...

NanoString Spatial Biology Roadmap: Whole Transcriptome Digital Spatial Profiling and Sub-Cellular Multi-Omic Imaging with the Spatial Molecular Imager Join NanoString Chief Scientific Officer and ...

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) today announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquartered in ...

When NanoString Technologies—a pioneering spatial biology company in Seattle—filed for bankruptcy in February this year, the future of the company and its technology remained unknown. Although Joe ...

A little more than two months ago, NanoString Technologies filed for bankruptcy – weary from having to pay $31 million to 10X Genomics after losing a patent infringement lawsuit. Today is a different ...